U.S. Interactive Media and Services Stock News

NasdaqGS:NSSC
NasdaqGS:NSSCElectronic

Is It Too Late To Consider Napco Security Technologies (NSSC) After A 93% One Year Rally?

If you are wondering whether Napco Security Technologies' current share price reflects its true worth, you are not alone. Many investors are trying to work out if the recent run still leaves room for value. The stock closed at US$46.61, with returns of 1.6% over the last 7 days, 26.3% over 30 days, 12.6% year to date and 92.9% over 1 year. The 3 year and 5 year returns stand at 47.4% and 182.8% respectively. Recent news coverage has largely focused on Napco Security Technologies as a...
NasdaqGS:BL
NasdaqGS:BLSoftware

Is BlackLine (BL) Now Attractive After A Multi Year Share Price Slide

If you are wondering whether BlackLine is starting to look interesting at today’s price, this article will walk through what that current market value might be implying about the business. BlackLine’s share price recently closed at US$35.25, with returns of 2.5% decline over 7 days, 24.1% decline over 30 days, 34.5% decline year to date, 27.0% decline over 1 year, 50.0% decline over 3 years, and 68.4% decline over 5 years that may have reshaped how the market views its potential and...
NYSE:GM
NYSE:GMAuto

Does Iowa’s OnStar Data Lawsuit Reshape the Bull Case for General Motors’ Software Ambitions (GM)?

Iowa Attorney General Brenna Bird has sued General Motors and its OnStar unit, alleging they collected and sold detailed driving data from Iowans without consent since 2015, in violation of the Iowa Consumer Fraud Act. The case spotlights how GM’s push to monetize connected-vehicle data through services like OnStar can collide with evolving expectations around privacy and transparency. We’ll now examine how this alleged misuse of OnStar driving data could affect GM’s investment narrative...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

Is NovoCure (NVCR) Pricing Look Out Of Step With Recent Share Rebound

If you are looking at NovoCure and wondering whether the recent share price makes sense, this article will walk through what that price might be implying about the stock's value. The shares last closed at US$13.67, with returns of 20.3% over the past 7 days and 10.2% over 30 days, set against a 4.2% return year to date and a 28.3% decline over 1 year, and an 82.5% and 89.4% decline over 3 and 5 years respectively. Recent news coverage around NovoCure has focused on the company as a Nasdaq...
NasdaqGS:GTM
NasdaqGS:GTMInteractive Media and Services

Assessing ZoomInfo Technologies (GTM) Valuation After Nvidia CEO Support And AI Initiatives

ZoomInfo Technologies (GTM) moved back into focus after Nvidia CEO Jensen Huang argued that artificial intelligence is more likely to support, not threaten, enterprise software providers such as ZoomInfo. See our latest analysis for ZoomInfo Technologies. Even after reacting positively to Jensen Huang’s comments, ZoomInfo’s share price remains under pressure, with a 30 day share price return of 22.86% and a 1 year total shareholder return of 46.74%. This indicates that recent momentum has...
NYSE:TRGP
NYSE:TRGPOil and Gas

Is It Too Late To Reassess Targa Resources (TRGP) After Strong Recent Share Gains?

If you are looking at Targa Resources and wondering whether the current share price still makes sense, you are not alone. The stock last closed at US$235.80, with returns of 1.9% over 7 days, 17.3% over 30 days, 26.3% year to date and 19.6% over 1 year, while the 3 year return is very large and the 5 year return is also very large. Recent news flow around Targa Resources has focused on its position in the energy infrastructure space and how investor sentiment has been reflecting that...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Assessing Recursion Pharmaceuticals (RXRX) After A 51% One Year Share Price Decline

If you are wondering whether Recursion Pharmaceuticals' current share price makes sense, the key question is how that price compares with what the business could reasonably be worth. The stock last closed at US$3.67, with a 7 day return of 7.3%, a 30 day return decline of 12.4%, a year to date return decline of 12.6%, and a 1 year return decline of 51.1%. These figures will shape how many investors think about its potential and risk today. Recent coverage has focused on Recursion...
NasdaqGS:GDRX
NasdaqGS:GDRXHealthcare Services

Is GoodRx (GDRX) Using Employer Direct to Redefine Its Role in Workplace Drug Benefits?

GoodRx Holdings recently reported fourth-quarter 2025 results, issued 2026 revenue guidance of US$750 million to US$780 million, updated progress on its share buyback, filed a US$74.72 million shelf registration for an ESOP-related Class A stock offering, and disclosed several analyst rating changes. The company also launched GoodRx Employer Direct, a new program that lets employers directly subsidize high-cost drugs like GLP-1s at the pharmacy counter, potentially widening GoodRx’s role in...
NYSEAM:NHC
NYSEAM:NHCHealthcare

The Bull Case For National HealthCare (NHC) Could Change Following Strong 2025 Results And White Oak Acquisition

National HealthCare Corporation reported past fourth-quarter 2025 revenue of US$386.51 million and net income of US$24.85 million, with full‑year 2025 revenue of US$1.52 billion and net income of US$120.02 million, all higher than the prior year. The company highlighted that growth was supported both by higher same‑facility revenues and the contribution from its White Oak Manor acquisition, underscoring the role of expansion alongside core operations in its 2025 results. With this backdrop...
NYSE:GXO
NYSE:GXOLogistics

GXO Wins Hunkemöller’s First Outsourced B2B Logistics Deal Might Change The Case For Investing In GXO (GXO)

GXO Logistics, Inc. announced that it successfully launched a multi-year partnership with lingerie retailer Hunkemöller, taking over its B2B logistics operations in Almere from January 1, 2026, using a 32,000-square-meter, highly automated site to support pan-European distribution. This is Hunkemöller’s first move to outsource B2B logistics, underscoring GXO’s role as a technology-led logistics partner integrating robotics and shuttle systems into a single, large-scale European hub. Next,...
NasdaqGS:PCRX
NasdaqGS:PCRXPharmaceuticals

Pacira BioSciences (PCRX) Valuation Check After Mixed Share Performance And High P/E Multiple

Why Pacira BioSciences is on investors’ radar today Pacira BioSciences (PCRX) has been drawing attention after a mixed share price pattern, with a 6.7% gain over the past month contrasting with negative returns over the past 3 months and year to date. See our latest analysis for Pacira BioSciences. At the current share price of $21.91, Pacira BioSciences shows a mixed picture, with a 6.7% 30 day share price return set against a 10.4% year to date share price decline and a 68.3% five year...
NasdaqGS:INTR
NasdaqGS:INTRBanks

Assessing Inter & Co (NasdaqGS:INTR) Valuation After Strong Multi‑Year Shareholder Returns

With no fresh headline driving Inter & Co (NasdaqGS:INTR) today, recent performance and fundamentals come into focus as investors weigh its returns profile against revenue of R$5,984.585 and net income of R$1,312.39. See our latest analysis for Inter & Co. Inter & Co’s share price has eased in the short term, with a 7 day share price return of 5.84% and 30 day share price return of 6.65%, yet its 1 year total shareholder return of 64.56% and 3 year total shareholder return of almost 4x...
NYSE:CON
NYSE:CONHealthcare

Earnings Beat, Dividend Hike, and Buybacks Might Change The Case For Investing In Concentra (CON)

Concentra Group Holdings Parent, Inc. recently reported its fourth-quarter and full-year 2025 results, with Q4 revenue rising to US$539.08 million and net income to US$34.69 million, while also declaring a US$0.0625 per-share cash dividend payable in March 2026. Management is pairing this earnings momentum with expansion plans focused on smaller, bolt-on acquisitions and a stepped-up de novo clinic pipeline, supported by a new US$100.00 million share repurchase program. We’ll now examine how...
NYSE:CNH
NYSE:CNHMachinery

Why CNH Industrial (CNH) Is Down 5.8% After Weaker Earnings and a Sharper “Iron + Tech” Pivot

In February 2026, CNH Industrial N.V. reported fourth-quarter 2025 results showing revenue rising to US$5,157 million while quarterly net income fell to US$86 million, and full-year 2025 earnings declined to US$510 million on revenue of US$18,095 million. Despite this earnings pressure, the company’s latest 10-K filing emphasized its “Iron + Tech” approach, prioritizing precision agriculture, automation, and connectivity to reshape its equipment and services model. We’ll now examine how this...
NYSE:AX
NYSE:AXBanks

Why Axos Financial (AX) Is Down 10.8% After Hot PPI Rekindles Fed Rate Cut Doubts

In late February 2026, Axos Financial, a digital-focused US bank, was caught in a broad financial sector downturn after a higher-than-expected January Producer Price Index reading reinforced concerns about persistent inflation and constrained room for near-term Federal Reserve rate cuts. This inflation surprise matters for Axos because sustained elevated rates can pressure bank net interest margins, directly affecting how profitably it turns deposits into loans and other interest-earning...
NYSE:ADC
NYSE:ADCRetail REITs

A Look At Agree Realty (ADC) Valuation After Recent Share Price Momentum And Premium P/E Multiple

Agree Realty (ADC) has drawn attention after its recent share performance, with the stock last closing at $80.48. For income focused investors, the real estate investment trust’s profile may warrant a closer look. See our latest analysis for Agree Realty. The recent 11.8% 1 month share price return, on top of an 11.6% year to date share price return, sits alongside a 5 year total shareholder return of 54.4%, suggesting momentum has been building over both shorter and longer horizons. If this...
NYSE:SSB
NYSE:SSBBanks

Why SouthState Bank (SSB) Is Down 6.4% After Inflation Jolt Hits Regional Lenders

In late February 2026, SouthState Bank was caught up in a broad financial sector pullback after hotter-than-expected U.S. producer inflation data and renewed concerns about banks’ credit quality and loan performance. The episode underscored how macroeconomic inflation surprises and shifting expectations for Federal Reserve policy can quickly alter sentiment toward regional lenders’ balance-sheet risks. Next, we’ll examine how these inflation and credit-quality concerns interact with...
NYSE:XPOF
NYSE:XPOFHospitality

Assessing Xponential Fitness (XPOF) Valuation After Weak Earnings And Lower 2026 Revenue Guidance

Xponential Fitness (XPOF) is back in focus after reporting fourth quarter and full year 2025 results, along with 2026 revenue guidance that points to a lower range than the prior year. See our latest analysis for Xponential Fitness. The earnings release and lower 2026 revenue guidance have coincided with sharp share price weakness, with a 1 day share price return of 47.08% decline and a 1 year total shareholder return of 67.75% decline. This points to fading momentum and a reassessment of...
NYSE:VMC
NYSE:VMCBasic Materials

Is Vulcan Materials (VMC) Fully Priced After Strong Multi Year Share Price Gains

If you are wondering whether Vulcan Materials is a fair deal at around US$310 per share, it helps to step back and look at what the current price actually reflects. The stock last closed at US$310.00, with returns of 1.5% over 7 days, 3.1% over 30 days, 5.9% year to date, 26.3% over 1 year, 73.4% over 3 years and 92.3% over 5 years, which may shape how investors are thinking about its potential and its risks today. Recent coverage has focused on Vulcan Materials as a key supplier of...
NYSE:MDU
NYSE:MDUGas Utilities

Will Steady Dividends And A US$3.10 Billion Plan Shift MDU Resources Group's (MDU) Narrative

MDU Resources Group’s board recently declared a quarterly dividend of US$0.14 per share, unchanged from the prior quarter, payable on April 1, 2026 to shareholders of record on March 12, 2026, while continuing to target a long-term payout ratio of 60% to 70% of earnings. Alongside reaffirmed earnings guidance and a multi-year US$3.10 billion capital plan as a pure-play regulated utility and pipeline operator, the full exit of activist investor Corvex Management highlights an evolving...
NasdaqGS:CATY
NasdaqGS:CATYBanks

Cathay General Bancorp (CATY) Is Down 7.1% After Commercial Real Estate Credit Concerns Intensify

In recent days, Cathay General Bancorp has come under pressure as investors reacted to rising credit risk concerns amid hotter-than-expected inflation data and growing worries over regional banks’ exposure to commercial real estate. What makes this episode especially important is that it coincides with Cathay General’s flat sales and declining earnings per share, sharpening questions about its profitability and growth profile. We’ll now examine how heightened credit risk concerns,...
NYSE:VTOL
NYSE:VTOLEnergy Services

A Look At Bristow Group (VTOL) Valuation After Earnings, 2026 Outlook, Refinancing And New Dividend

Earnings, guidance and capital returns in focus Bristow Group (VTOL) just paired its fourth quarter and full year 2025 results with 2026 guidance, a fresh quarterly dividend and details on a recent US$500 million refinancing at a lower coupon. The company reported Q4 2025 sales of US$377.26 million and net income of US$18.42 million, while affirming 2026 revenue expectations in a US$1.58 billion to US$1.69 billion range and maintaining its new US$0.125 quarterly cash dividend. See our latest...
NasdaqGS:MASI
NasdaqGS:MASIMedical Equipment

Masimo (MASI) Valuation Check After Sharp Near‑Term Rebound And Modest Undervaluation Narrative

Why Masimo is on investor watchlists right now Masimo (MASI) has recently drawn fresh attention after a strong month in the stock, with returns over the past 3 months also standing out against a weaker 1 year total return. See our latest analysis for Masimo. The recent 27.69% 1 month share price return and 21.75% 3 month share price return, against a 1 year total shareholder return decline of 7.11%, suggests short term momentum has picked up while longer term holders are still under water at...
NasdaqGS:ZM
NasdaqGS:ZMSoftware

Zoom (ZM) Is Down 18.1% After Mixed Earnings and New AI Narrative - What's Changed

In late February 2026, Zoom Communications reported fourth-quarter revenue of about US$1.25 billion and net income of US$674.08 million, capping a full year with sales of US$4.87 billion and net income of US$1.90 billion, alongside new guidance for fiscal 2027 and completion of a US$2.70 billion share buyback program. Beyond its core operations, Zoom highlighted growing traction in AI-powered products and the potential value of its early-stage investment in Anthropic, which some commentators...